KREF-PA Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

GAAP Net Loss: $32 million, or $0.49 per share.

Book Value: $13.04 as of December 31, 2025.

Distributable Earnings: $14 million, or $0.22 per share.

Dividend: $0.25 cash dividend declared for Q4.

Liquidity: Over $880 million, including $85 million cash and $700 million undrawn on the corporate revolver.

Repurchases: $9 million of common stock repurchased in Q4 at an average price of $8.24; total repurchases for 2025 were $43 million.

2Strategic Updates and Business Highlights

Liquidity Position: Strengthened through a $650 million Term Loan B and upsizing of the corporate revolver to $700 million.

Geographic Expansion: Closed on the first loan in Europe, marking a significant step in diversifying the real estate credit platform.

Portfolio Composition: Over 75% of new originations in 2025 were in multifamily and industrial loans, sectors with resilient fundamentals.

Resolution Strategy: Plans to aggressively resolve watch list and REO assets to unlock approximately $0.13 per share embedded value.

3Forward Guidance and Outlook

2026 Transition Year: Expected to focus on liquidity and resolution strategies for REO and watch list assets, which may pressure earnings in the short term.

Repayment Expectations: Anticipate over $1.5 billion in repayments in 2026, exceeding the previous two years.

Dividend Policy: Under evaluation as part of capital allocation discussions, prioritizing long-term shareholder value over short-term sentiment.

4Bad News, Challenges, or Points of Concern

Net Loss: The company reported a significant net loss for the quarter.

Asset Quality Issues: Downgrades of loans in the Cambridge Life Science and San Diego multifamily sectors, resulting in $44 million in CECL provisions.

Market Conditions: Ongoing challenges in the life science sector and potential for further downgrades in the watch list assets.

Earnings Pressure: The aggressive resolution strategy may lead to additional pressure on earnings until fully executed.

5Notable Q&A Insights

Portfolio Overhaul: Management is considering a more aggressive approach to liquidate underperforming assets, similar to strategies employed by peers.

Life Science Sector Outlook: Concerns about a prolonged recovery in the life science sector, with management acknowledging the potential for a lengthy turnaround.

Market Sentiment: Management is optimistic about the market recognizing the value of a cleaned-up portfolio, despite current trading at a discount to book value.

Office Loan Strategy: Focus on high-quality, stabilized office assets with long-term leases, while being cautious about legacy office loans. Overall, KREF-PA is navigating a challenging environment with a focus on liquidity, strategic asset resolution, and maintaining a balance between immediate earnings and long-term value creation.